ask="12.75"
ask_size="400"
average_daily_volume="1813950"
bid="9.12"
bid_size="200"
book_value="-0.09"
change="+0.23"
change_from_200_day_moving_average="1.08"
change_from_50_day_moving_average="0.18"
change_from_52_week_high="-2.11"
change_From_52_week_low="4.75"
change_in_percent="+1.91%"
close="12.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94803000"
high="12.27"
high_52_weeks="14.38"
last_trade_date="2/24/2017"
last_trade_price="12.27"
last_trade_size="25045"
last_trade_time="4:00pm"
low="11.82"
low_52_weeks="7.52"
market_capitalization="1.57B"
moving_average_200_day="11.19"
moving_average_50_day="12.09"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="11.84"
pe_ratio="N/A"
peg_ratio="-0.25"
percent_change_from_200_day_moving_average="+9.68%"
percent_change_from_50_day_moving_average="+1.48%"
percent_change_from_52_week_high="-14.67%"
percent_change_from_52_week_low="+63.16%"
previous_close="12.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.65"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="HALO"
volume="1253648"
weeks_range_52="7.52 - 14.38"
